Found 10 matching trials
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma PHASE2 This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Learn More & Join Trial
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma PHASE3 This is a Phase 3, Open-Label, Multicenter, Randomised, Controlled Study de...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer PHASE2 This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC PHASE2 Approximately 20 participants will be enrolled in the study to evaluate the...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Learn More & Join Trial
Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial PHASE2 This study aims to evaluate the efficacy of disitamab vedotin combined with...
Show More Location
Multiple Locations
Learn More & Join Trial
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC PHASE2 This is a multicenter, randomized controlled clinical trial (HOPE-07) desig...
Show More Location
Multiple Locations
Learn More & Join Trial
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer PHASE2 This is a multicenter, prospective, open-label, Phase II, four-arm parallel...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer PHASE2 The purpose of this study is to evaluate the Safety and Efficacy of Neoadju...
Show More Location
Xiangya Hospital Central South University
Learn More & Join Trial